Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
Mol Ther
.
2023 May 3;31(5):1196-1200.
doi: 10.1016/j.ymthe.2023.03.033.
Authors
Yan Leyfman
1
,
Greta Gohring
2
,
Muskan Joshi
3
,
Gayathri Pramil Menon
3
,
Alexandra Van de Kieft
4
,
Tania Del Rivero
2
,
Michael A Bellio
2
,
Maria Ines Mitrani
5
Affiliations
1
Icahn School of Medicine at Mount Sinai South Nassau, Oceanside, NY, USA.
2
Organicell Regenerative Medicine, Davie, FL, USA.
3
Tbilisi State Medical University, Tbilisi, Georgia.
4
Cornell University, Ithaca, NY, USA.
5
Organicell Regenerative Medicine, Davie, FL, USA. Electronic address: mari@organicell.com.
PMID:
37141856
PMCID:
PMC10155280
DOI:
10.1016/j.ymthe.2023.03.033
No abstract available
MeSH terms
COVID-19*
Extracellular Vesicles*
Humans
SARS-CoV-2